Related Tags >> FDA Humira AstraZeneca pharmaceuticals

Abbott Labs News

Most Popular Abbott Labs Story

13 Big Pharmas to collaborate on $785M fight against neglected diseases

January 30, 2012 — 8:37am ET | By John Carroll

Top executives from a slate of the world's biggest pharma companies will be rubbing shoulders with Bill Gates today as they roll out an ambitious plan to join hands on a $785 million effort to Read more...

Abbott Labs Press Releases

Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Next-Generation Antioxidant Inflammation Modula
Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer
Abbott to Separate into Two Leading Companies in Diversified Medical Products and Research-Based Pharmaceuticals
Abbott Introduces New ALK Genetic Test for Specific Form of Non-Small-Cell Lung Cancer
Abbott Receives FDA Approval for ALK Gene Test for Lung Cancer Therapy Selection

Latest Headlines

Richard A. Gonzalez - The 25 most influential people in biopharma today
February 7, 2012
13 Big Pharmas to collaborate on $785M fight against neglected diseases
January 30, 2012
JPM kicks off with fevered focus on the next big biotech deal
January 9, 2012
Abbott nixes cancer drug alliance with Emergent BioSolutions
December 29, 2011
UPDATED: Abbott bets $400M on mega-blockbuster future for Reata program
December 12, 2011
Abbott chief says biopharma ops not for sale (at bargain price)
December 5, 2011
Lilly CEO vows to steer clear of Abbott, stick with deals and alliances
October 25, 2011
Abbott spotlights blockbuster hopefuls in pitching spinoff
October 24, 2011
Will Abbott spinoff become Big Pharma's next big M&A target?
October 20, 2011
Abbott split creates an $18B biopharma deal-maker with deep pockets
October 19, 2011
Abbott deals beef up late-stage platform of blockbuster contenders
September 14, 2011
Pfizer (finally) wins a big one with crizotinib approval for lung cancer
August 28, 2011
Biogen, Abbott tout promising MS data from PhIIb daclizumab trial
August 9, 2011
Abbott inks $470M pact for Biotest's Ph2 RA antibody program
June 21, 2011
Seattle Genetics strikes again with $208M ADC deal with Abbott
March 22, 2011
Abbott chops 1,900 workers after experimental drugs flop
January 26, 2011
AZ, Abbott dump heart drug
December 23, 2010
2010: The R&D revolution-Phase II
December 23, 2010
Myriad gains from Abbott testing deal
October 27, 2010
Reata scores $450M in quick cash from Abbott pact
September 23, 2010

Paid Research Reports

More Research Reports >>

Free Newsletter

Most Popular Stories

Webinars

Hottest Products

Featured Jobs

Events